TRIPHARMA
ActiveSummary
TRIPHARMA has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€28,957) and a net result of €68,582. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 18% of 22,554 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Directors
Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.